| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 10 | 2016 | 406 | 0.930 |
Why?
|
| DNA Transposable Elements | 6 | 2011 | 50 | 0.900 |
Why?
|
| Retroelements | 7 | 2010 | 14 | 0.750 |
Why?
|
| Gene Expression Profiling | 10 | 2016 | 683 | 0.500 |
Why?
|
| Evolution, Molecular | 7 | 2010 | 299 | 0.490 |
Why?
|
| Terminal Repeat Sequences | 4 | 2010 | 8 | 0.390 |
Why?
|
| Neoplastic Stem Cells | 2 | 2011 | 94 | 0.380 |
Why?
|
| Ovary | 2 | 2009 | 112 | 0.360 |
Why?
|
| Repressor Proteins | 3 | 2019 | 267 | 0.350 |
Why?
|
| Drosophila melanogaster | 2 | 2004 | 189 | 0.350 |
Why?
|
| Open Reading Frames | 3 | 2007 | 81 | 0.340 |
Why?
|
| Prostatic Neoplasms | 5 | 2023 | 1068 | 0.340 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 557 | 0.330 |
Why?
|
| Multipotent Stem Cells | 1 | 2009 | 16 | 0.320 |
Why?
|
| Chromatin | 2 | 2011 | 179 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 3 | 2019 | 534 | 0.270 |
Why?
|
| Epithelial Cells | 2 | 2011 | 426 | 0.270 |
Why?
|
| Paired Box Transcription Factors | 1 | 2006 | 7 | 0.260 |
Why?
|
| Cell Line, Tumor | 13 | 2025 | 2598 | 0.260 |
Why?
|
| Fallopian Tubes | 1 | 2006 | 19 | 0.260 |
Why?
|
| Transcription Factors | 5 | 2019 | 722 | 0.260 |
Why?
|
| Phylogeny | 9 | 2010 | 740 | 0.230 |
Why?
|
| Cell Proliferation | 6 | 2025 | 1420 | 0.230 |
Why?
|
| Computational Biology | 3 | 2006 | 324 | 0.230 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2025 | 23 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2019 | 62 | 0.220 |
Why?
|
| Coat Protein Complex I | 1 | 2004 | 1 | 0.220 |
Why?
|
| COP-Coated Vesicles | 1 | 2004 | 1 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2019 | 933 | 0.220 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 61 | 0.210 |
Why?
|
| DNA Helicases | 1 | 2004 | 46 | 0.210 |
Why?
|
| DNA Polymerase II | 1 | 2003 | 6 | 0.210 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 83 | 0.210 |
Why?
|
| Schizosaccharomyces | 1 | 2003 | 16 | 0.210 |
Why?
|
| Genome, Fungal | 1 | 2003 | 28 | 0.210 |
Why?
|
| Histone Deacetylases | 1 | 2004 | 61 | 0.210 |
Why?
|
| Genome | 2 | 2007 | 149 | 0.210 |
Why?
|
| Nicardipine | 1 | 2023 | 8 | 0.210 |
Why?
|
| Animals | 19 | 2025 | 16695 | 0.200 |
Why?
|
| Protein Transport | 1 | 2004 | 295 | 0.200 |
Why?
|
| Sequence Analysis, DNA | 2 | 2010 | 508 | 0.200 |
Why?
|
| Humans | 32 | 2025 | 42163 | 0.200 |
Why?
|
| Caenorhabditis elegans | 2 | 2002 | 78 | 0.200 |
Why?
|
| Eukaryotic Cells | 1 | 2002 | 36 | 0.190 |
Why?
|
| Membrane Proteins | 2 | 2016 | 548 | 0.190 |
Why?
|
| Molecular Sequence Data | 7 | 2009 | 1559 | 0.190 |
Why?
|
| Internet | 1 | 2004 | 234 | 0.190 |
Why?
|
| Software | 1 | 2004 | 234 | 0.180 |
Why?
|
| Cathepsin L | 2 | 2019 | 16 | 0.180 |
Why?
|
| Cell Cycle | 4 | 2019 | 348 | 0.180 |
Why?
|
| Euchromatin | 1 | 2001 | 6 | 0.180 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 287 | 0.180 |
Why?
|
| Antineoplastic Agents | 3 | 2025 | 979 | 0.180 |
Why?
|
| Genome, Human | 3 | 2011 | 143 | 0.180 |
Why?
|
| Amino Acid Sequence | 5 | 2004 | 1188 | 0.170 |
Why?
|
| Systems Biology | 2 | 2011 | 26 | 0.160 |
Why?
|
| Retroviridae | 1 | 1999 | 25 | 0.160 |
Why?
|
| CCAAT-Binding Factor | 1 | 2019 | 3 | 0.150 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 228 | 0.150 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 2007 | 36 | 0.150 |
Why?
|
| Peroxidase | 1 | 2019 | 57 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2019 | 24 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 78 | 0.150 |
Why?
|
| Vitis | 1 | 2019 | 37 | 0.150 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2016 | 57 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 1 | 2019 | 120 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 144 | 0.140 |
Why?
|
| Centrosome | 2 | 2015 | 30 | 0.140 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2017 | 222 | 0.140 |
Why?
|
| Genitalia | 1 | 2017 | 18 | 0.130 |
Why?
|
| DNA Methylation | 3 | 2007 | 393 | 0.130 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2017 | 33 | 0.130 |
Why?
|
| Transfection | 3 | 2015 | 526 | 0.130 |
Why?
|
| Chlamydia trachomatis | 1 | 2017 | 69 | 0.130 |
Why?
|
| Dendritic Cells | 1 | 2017 | 130 | 0.130 |
Why?
|
| Endogenous Retroviruses | 2 | 2006 | 17 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2016 | 61 | 0.120 |
Why?
|
| Gene Regulatory Networks | 3 | 2016 | 143 | 0.120 |
Why?
|
| Plant Extracts | 1 | 2019 | 303 | 0.120 |
Why?
|
| Female | 15 | 2018 | 24018 | 0.120 |
Why?
|
| Chlamydia Infections | 1 | 2017 | 199 | 0.110 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2014 | 28 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2019 | 2111 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 382 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2004 | 271 | 0.100 |
Why?
|
| Oxidative Stress | 1 | 2019 | 990 | 0.100 |
Why?
|
| Testosterone | 1 | 2014 | 211 | 0.100 |
Why?
|
| Mice | 6 | 2025 | 6490 | 0.100 |
Why?
|
| Drosophila | 2 | 2008 | 150 | 0.100 |
Why?
|
| Up-Regulation | 4 | 2017 | 534 | 0.090 |
Why?
|
| Gene Expression | 2 | 2014 | 692 | 0.090 |
Why?
|
| Sound | 1 | 2012 | 8 | 0.090 |
Why?
|
| Histones | 3 | 2011 | 194 | 0.090 |
Why?
|
| Cell Separation | 1 | 2011 | 94 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 207 | 0.090 |
Why?
|
| Apoptosis | 4 | 2023 | 1541 | 0.090 |
Why?
|
| Sulfoglycosphingolipids | 1 | 2010 | 1 | 0.080 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 479 | 0.080 |
Why?
|
| Phenotype | 2 | 2011 | 774 | 0.080 |
Why?
|
| Adenocarcinoma, Papillary | 1 | 2009 | 3 | 0.080 |
Why?
|
| Frozen Sections | 1 | 2009 | 7 | 0.080 |
Why?
|
| Microdissection | 1 | 2009 | 13 | 0.080 |
Why?
|
| Adult Stem Cells | 1 | 2009 | 12 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 339 | 0.080 |
Why?
|
| Lasers | 1 | 2009 | 57 | 0.080 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2009 | 11 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2011 | 633 | 0.080 |
Why?
|
| Ovarian Diseases | 1 | 2008 | 4 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 279 | 0.070 |
Why?
|
| Male | 8 | 2025 | 22779 | 0.070 |
Why?
|
| Microspheres | 1 | 2009 | 49 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 165 | 0.070 |
Why?
|
| DNA | 1 | 2012 | 594 | 0.070 |
Why?
|
| Leukemia, T-Cell | 1 | 2008 | 6 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 55 | 0.070 |
Why?
|
| Dosage Compensation, Genetic | 1 | 2008 | 8 | 0.070 |
Why?
|
| Lipids | 1 | 2010 | 256 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 649 | 0.070 |
Why?
|
| Recombination, Genetic | 2 | 2010 | 96 | 0.070 |
Why?
|
| Carcinoma | 1 | 2008 | 106 | 0.070 |
Why?
|
| Cluster Analysis | 3 | 2014 | 206 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 2009 | 273 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1679 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2016 | 310 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2007 | 28 | 0.070 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 14 | 0.070 |
Why?
|
| Cell Survival | 3 | 2019 | 934 | 0.070 |
Why?
|
| Multigene Family | 2 | 2010 | 105 | 0.060 |
Why?
|
| Pan troglodytes | 1 | 2006 | 21 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 436 | 0.060 |
Why?
|
| Proteomics | 2 | 2019 | 363 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2011 | 501 | 0.060 |
Why?
|
| Chromosome Mapping | 2 | 2003 | 198 | 0.060 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2004 | 1 | 0.050 |
Why?
|
| Genes, Insect | 1 | 2004 | 27 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 928 | 0.050 |
Why?
|
| Conserved Sequence | 1 | 2004 | 121 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 95 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2004 | 30 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2016 | 403 | 0.050 |
Why?
|
| Sexual Behavior, Animal | 1 | 2004 | 64 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 135 | 0.050 |
Why?
|
| Models, Genetic | 2 | 2006 | 181 | 0.050 |
Why?
|
| Chromosomes, Fungal | 1 | 2003 | 4 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2003 | 35 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 139 | 0.050 |
Why?
|
| Autoantigens | 1 | 2004 | 85 | 0.050 |
Why?
|
| Genomics | 1 | 2006 | 289 | 0.050 |
Why?
|
| Gene Expression Regulation | 3 | 2009 | 1066 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 427 | 0.050 |
Why?
|
| Ribonuclease H | 1 | 2002 | 11 | 0.050 |
Why?
|
| Alleles | 1 | 2004 | 352 | 0.050 |
Why?
|
| Genes | 1 | 2002 | 56 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2004 | 190 | 0.050 |
Why?
|
| DNA, Intergenic | 1 | 2002 | 11 | 0.050 |
Why?
|
| Immune System | 1 | 2002 | 40 | 0.050 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 183 | 0.050 |
Why?
|
| Cell Movement | 2 | 2019 | 640 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2004 | 318 | 0.050 |
Why?
|
| Reproduction | 1 | 2002 | 92 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 1804 | 0.040 |
Why?
|
| Neoplasm Staging | 2 | 2014 | 366 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2002 | 383 | 0.040 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1999 | 17 | 0.040 |
Why?
|
| Gene Products, env | 1 | 1999 | 23 | 0.040 |
Why?
|
| Gluconeogenesis | 1 | 2019 | 15 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2017 | 1617 | 0.040 |
Why?
|
| Disease Progression | 2 | 2015 | 661 | 0.040 |
Why?
|
| Prognosis | 2 | 2014 | 850 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2019 | 64 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 90 | 0.040 |
Why?
|
| Middle Aged | 4 | 2018 | 11819 | 0.040 |
Why?
|
| Aged | 3 | 2018 | 7982 | 0.040 |
Why?
|
| Cadherins | 1 | 2018 | 102 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 2 | 2008 | 26 | 0.030 |
Why?
|
| Base Sequence | 3 | 2009 | 997 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 2017 | 21 | 0.030 |
Why?
|
| Cell Line | 2 | 2011 | 1416 | 0.030 |
Why?
|
| Prostate | 1 | 2018 | 152 | 0.030 |
Why?
|
| Breast | 1 | 2018 | 139 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2017 | 59 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2017 | 57 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2017 | 86 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1997 | 63 | 0.030 |
Why?
|
| Epigenesis, Genetic | 2 | 2011 | 274 | 0.030 |
Why?
|
| Receptor, erbB-3 | 1 | 2016 | 17 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 168 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 599 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2015 | 24 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2015 | 34 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 30 | 0.030 |
Why?
|
| Receptor, erbB-2 | 1 | 2016 | 149 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2016 | 214 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2015 | 102 | 0.030 |
Why?
|
| Adult | 3 | 2018 | 13458 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2014 | 129 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 116 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 84 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 452 | 0.030 |
Why?
|
| Microtubules | 1 | 2015 | 120 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2017 | 1010 | 0.030 |
Why?
|
| Hela Cells | 1 | 2015 | 370 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 64 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 144 | 0.030 |
Why?
|
| Mitochondria | 1 | 2017 | 516 | 0.030 |
Why?
|
| Mitosis | 1 | 2014 | 112 | 0.030 |
Why?
|
| Lung | 1 | 2016 | 484 | 0.020 |
Why?
|
| Ultrasonic Therapy | 1 | 2012 | 4 | 0.020 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2012 | 10 | 0.020 |
Why?
|
| Methods | 1 | 2011 | 14 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2011 | 5 | 0.020 |
Why?
|
| K562 Cells | 1 | 2011 | 32 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2011 | 37 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2803 | 0.020 |
Why?
|
| Neoplasms | 1 | 2002 | 1341 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2012 | 77 | 0.020 |
Why?
|
| Plasmids | 1 | 2012 | 247 | 0.020 |
Why?
|
| Age Factors | 1 | 2014 | 1139 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 284 | 0.020 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 93 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1554 | 0.020 |
Why?
|
| DNA, Plant | 1 | 2010 | 10 | 0.020 |
Why?
|
| Genome, Plant | 1 | 2010 | 29 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2012 | 330 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 239 | 0.020 |
Why?
|
| Burkitt Lymphoma | 1 | 2009 | 25 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 290 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2008 | 79 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 158 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1112 | 0.020 |
Why?
|
| Tretinoin | 1 | 2009 | 50 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 421 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2008 | 20 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2008 | 84 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2009 | 190 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 236 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2008 | 74 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 100 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 362 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 670 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 167 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2007 | 19 | 0.020 |
Why?
|
| Azacitidine | 1 | 2007 | 22 | 0.020 |
Why?
|
| Drug Design | 1 | 2008 | 183 | 0.020 |
Why?
|
| CpG Islands | 1 | 2007 | 107 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 1265 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 1051 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2007 | 230 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 1058 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 1729 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 2002 | 57 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2002 | 90 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2002 | 103 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2008 | 2485 | 0.010 |
Why?
|
| Genetic Code | 1 | 1997 | 7 | 0.010 |
Why?
|